|
Bartha, R; Drost, D J; Menon, R S et al. (2000) Comparison of the quantification precision of human short echo time (1)H spectroscopy at 1.5 and 4.0 Tesla. Magn Reson Med 44:185-92
|
|
Bartha, R; Drost, D J; Williamson, P C (1999) Factors affecting the quantification of short echo in-vivo 1H MR spectra: prior knowledge, peak elimination, and filtering. NMR Biomed 12:205-16
|
|
McKenzie, C A; Chen, Z; Drost, D J et al. (1999) Fast acquisition of quantitative T2 maps. Magn Reson Med 41:208-12
|
|
Potwarka, J J; Drost, D J; Williamson, P C et al. (1999) A 1H-decoupled 31P chemical shift imaging study of medicated schizophrenic patients and healthy controls. Biol Psychiatry 45:687-93
|
|
Bartha, R; al-Semaan, Y M; Williamson, P C et al. (1999) A short echo proton magnetic resonance spectroscopy study of the left mesial-temporal lobe in first-onset schizophrenic patients. Biol Psychiatry 45:1403-11
|
|
Bartha, R; Stein, M B; Williamson, P C et al. (1998) A short echo 1H spectroscopy and volumetric MRI study of the corpus striatum in patients with obsessive-compulsive disorder and comparison subjects. Am J Psychiatry 155:1584-91
|
|
Hinsberger, A D; Williamson, P C; Carr, T J et al. (1997) Magnetic resonance imaging volumetric and phosphorus 31 magnetic resonance spectroscopy measurements in schizophrenia. J Psychiatry Neurosci 22:111-7
|
|
Williamson, P C; Malla, A; Cortese, L et al. (1997) Phosphorus 31 magnetic resonance spectroscopy in patients with Huntington disease. Arch Gen Psychiatry 54:186-8
|
|
Bartha, R; Williamson, P C; Drost, D J et al. (1997) Measurement of glutamate and glutamine in the medial prefrontal cortex of never-treated schizophrenic patients and healthy controls by proton magnetic resonance spectroscopy. Arch Gen Psychiatry 54:959-65
|
|
Williamson, P C; Brauer, M; Leonard, S et al. (1996) 31P magnetic resonance spectroscopy studies in schizophrenia. Prostaglandins Leukot Essent Fatty Acids 55:115-8
|
Showing the most recent 10 out of 13 publications
